<DOC>
	<DOCNO>NCT00838864</DOCNO>
	<brief_summary>Prophylactic antibiotic routinely recommend cirrhotic patient upper gastrointestinal bleeding recently . However , regimen duration use remain inconclusive issue . Quinolones 3rd generation cephalosporin often use prophyalxis recently . The duration antibiotic usage variable literature , range 4-10 day . The late guideline AASLD 2007 7 day . In survey infection cirrhotic patient UGI bleed perform Bernard et al , infection occur first 5 day half within first 48 hour . Therefore , consider cost-effectiveness drug resistance issue , necessity prophylaxis 7 day may need re-evaluated . The purpose study investigate antibiotic prophylaxis duration cirrhotic patient acute gastro-esophageal variceal bleeding . We enroll patient suffer variceal bleeding document endoscopic examination without apparent evidence infection . Those received antibiotic within 2 week , less 18 year old , get pregnant , malignancy HCC , allergy ceftrioxone exclude . After receive well explanation give consent , patient randomly allocate 2 group receive prophylactic antibiotic endoscopic examination ; Group I : receive ceftriaxone 500 mg iv bolus stat q12h 3 day , Group II : receive ceftriaxone 500 mg iv bolus stat q12h 7 day . They receive appropriate endoscopic treatment gastro-esophgeal varix glypressin 1mg q6h 3 day . They start fee 2nd day contraindicate . The 2nd endoscopic treatment varix perform 2 week later . We record demographic data , vital sign , transfusion amount ; check hemogram , U/A , CXR , ascites routine ( apparent ascites ) , classification variceal size Child-Pugh classification . We monitor event rebleeding &amp; infection , transfusion amount hospitalization day We use rebleeding rate within 14 day primary end point . It define follow event initial stabilization vital sign 24 hour ; ( 1 ) : recurrence hematemesis bloody stool ( 2 ) ; need transfusion 2 unit blood systolic pressure &lt; 100 mmHg pulse rate &gt; 100/mn . We use infection rate admission mortality rate within 28 day secondary end point .</brief_summary>
	<brief_title>Comparison 3 Days 7 Days Intravenous Ceftriaxone Prophylaxis Variceal Bleeding</brief_title>
	<detailed_description>1 . Patient include &amp; exclude Criteria Including : Those diagnosed gastro-esophageal variceal bleed endoscopic examination . No evidence suggestive infection find include : 1 ) fever 37.5。C , 2 ) leucocytosis WBC &gt; 15000 mm3 immature neutrophils &gt; 500 mm3 , 3 ) PMN ascites 250/mm3，4 ) urinalysis , WBC &gt; 15 WBC/HPF , 5 ) suspect pneuminia CXR . Excluding:1 ) consent 2 ) already infection 3 ) antibiotic usage within 14 day 4 ) less 18 year old 5 ) pregnancy 6 ) malignancy HCC 7 ) allergy ceftriaxone 2 . Management , Allocation Prophylaxis Those esophageal variceal bleed receive edoscopic variceal ligation ; gastric variceal bleed receive Histoacryl injection therapy . They recieve glypressin 1mg q6h injection 3 day start feed second day contraindicate . We perform 2nd session endoscopic treatment 14 day later . These patient randomly alloacted 2 group recieve prophylactic antibiotic 1st endoscopic treatment ; Group I : ceftriaxone 500 mg iv bolus stat q12h 3 day , Group II : ceftriaxone 500 mg iv bolus stat q12h 7 day . If rebleeding occurs allocation , treatment decide attend physician . If active infection occur prophylaxis period improvement observe 24 hour , ceftriaxone use stop treatment decide attend physician . 3 . Data record Surveillance Data Record : We record basic data patietns : include : age , sex , co-morbidity ( CAD , heart failure , COPD , chronic liver renal disease , malignancy , etc ) ; hemogram allocation , U/A , transfusion amount , ascites routine significant ascites note , CXR , endoscopic finding varix ; low blood pressure allocation , Child-Pugh classification patient Surveillance : rebleeding infection admission , Transfusion amount hospitalization day allocation , rebleeding rate within 14 day &amp; mortality rate within 28 day . 4 . End point Primary end point : Rebleeding rate within 14 day initial endoscopic treatment . Definition rebleeding : following manifestation stabilization vital sign 24 hour , ( 1 ) appearance hematemesis bloody stool ( 2 ) need transfusion 2 unit blood vital sign change ( systolic pressure &lt; 100 mmHg heart rate &gt; 100 beats/min ) . Secondary end point : infection admission , mortality rate within 28 day . Definition infection : 1 ) bacteremia：positive blood culture , definite focus indentified , 2 ) spontaneous bacterial peritonitis : ascites routine : PMN &gt; 250/mm3 , 3 ) urinary tract infection : U/A WBC &gt; 15/HPF positive urine culture , 4 ) infection : suspect clinical , radiological bacterialogical examination , 5 ) respiratory tract infection : CXR change clinical evidence , 6 ) possible infection : fever ( &gt; 37.5。C 6 hour ) leucocytosis , WBC &gt; 15000 mm3 ，but negative blood culture</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<mesh_term>Esophageal Gastric Varices</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<criteria>patient suffer variceal bleeding document endoscopic examination without apparent evidence infection . receive antibiotic within 2 week , less 18 year old , get pregnant , malignancy HCC , allergy ceftrioxone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>variceal bleeding</keyword>
	<keyword>antibiotic prophylaxis</keyword>
	<keyword>ceftrioxone</keyword>
</DOC>